ENTECAVIR
- Product NDC
- 48792-7891
- 11-digit product format
- 487927891
- Labeler code
- 48792
- Product ID
- 48792-7891_a6b0bc76-b6a9-601c-e053-2a95a90aade3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ENTECAVIR
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Sunshine Lake Pharma Co., Ltd.
- Application
- ANDA211978
- Marketing category
- ANDA
- Marketing start
- 2020-05-20
- Marketing end
- 0000-00-00
- Substance
- ENTECAVIR
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 48792-7891-1 | 48792789101 | 30 TABLET, FILM COATED in 1 BOTTLE (48792-7891-1) | 2020-05-20 | 0000-00-00 | No | No | Current |
| 48792-7891-2 | 48792789102 | 90 TABLET, FILM COATED in 1 BOTTLE (48792-7891-2) | 2020-05-20 | 0000-00-00 | No | No | Current |